drugset / Trial / NCT00947466

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain

NCT00947466 ↗

Phase 1/2 Terminated 25 enrolled Mundipharma Research Limited
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to characterize the pharmacokinetics and tolerability of buprenorphine patches in children who require opioid pain relief for moderate to severe mouth pain.

Timeline

Start
2010-02
Primary completion
2012-11
Completion
2012-11

Outcome

Outcome not reported

Stopped (Enrollment): “25 patients have been recruited and it was considered that further recruitment would add no extra PK information”

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — Other